Thermo Fisher Scientific– tag –
-
CDMO Signal Ranks Viral Vector CDMOs: Thermo Fisher Scientific, AGC Biologics, and Takeda Lead Top Tier
CDMO Signal USA Overview CDMO Signal released its latest ranking of viral vector CDMOs, including AAV, lentiviral, and adenoviral modalities. Thermo Fisher Scientific, AGC Biologics, and Takeda secured top positions in the overall Signal... -
Thermo Fisher Scientific Seeks Bioprocess Digital Twin Data Scientist for CHO Cell Culture, Accelerating AI-Driven Optimization
Haystack USA Overview Thermo Fisher Scientific is hiring a Data Scientist to lead digital twin model development for CHO cell culture and upstream bioprocess workflows. This role involves hybrid modeling using AI, machine learning, and B... -
AI and Digital Twin Technologies Revolutionize Bioprocessing for Sustainable Manufacturing and Enhanced Efficiency
Facebook (CRB) USA Overview Integrating digital twin technology, advanced bioreactor design, and AI is transforming bioprocessing by reducing energy consumption and improving efficiency for sustainable manufacturing. AI accelerates enzym... -
Chemically Defined, Serum-Free Media Innovations Drive Market Expansion: AuctuCel Launches AI-Powered Medium, Gibco Achieves High CHO Cell Titer
Media City Scientific Singapore Overview Innovations in serum-free and chemically defined media are rapidly advancing, eliminating animal-derived components and boosting reproducibility in cell culture. Qkine launched FRS™ Pioneer, while... -
CDMOs Accelerate GLP-1 Manufacturing, Outpacing Traditional Facility Builds to Meet Soaring Demand
Pharma Advancement USA Overview Contract Development and Manufacturing Organizations (CDMOs) are rapidly scaling their manufacturing capabilities for GLP-1 receptor agonists, providing quicker solutions than ground-up facility constructi... -
Cell & Gene Therapy Manufacturing Faces Deepening Bottlenecks: AmplifyBio, Exothera Close; Thermo Fisher Cuts Viral Vector Jobs, but FDA Eases Regulations to Support Growth
Endpoints News Global Overview Despite cell and gene therapies becoming a commercial reality, manufacturing remains the primary bottleneck. The CDMO sector is struggling with overcapacity and underfunding, leading to closures like Amplif... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Perfusion Bioreactor Market Surges Driven by Continuous Biomanufacturing and Intensified Bioprocessing; Thermo Fisher’s DynaDrive Platform Leads
Constancy Researchers USA Overview The perfusion bioreactor market is experiencing rapid growth, primarily fueled by the adoption of continuous biomanufacturing and intensified bioprocessing strategies. Thermo Fisher Scientific's HyPerfo... -
Thermo Fisher Unveils DynaDrive 5L Single-Use Bioreactor, Enabling Seamless 1L to 5,000L Scale-Up for Biologics Manufacturing
Constancy Researchers USA Overview Thermo Fisher Scientific has launched its DynaDrive 5L single-use bioreactor, designed to enhance workflow efficiency in biopharmaceutical manufacturing. This new system facilitates seamless culture sca...
12